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Abstract
Background: Many patients with Parkinson’s disease (PD) have difficulties in performing a second task during
walking (i.e., dual task walking). Functional near-infrared spectroscopy (fNIRS) is a promising approach to study the
presumed contribution of dysfunction within the prefrontal cortex (PFC) to such difficulties. In this pilot study, we
examined the feasibility of using a new portable and wireless fNIRS device to measure PFC activity during different
dual task walking protocols in PD. Specifically, we tested whether PD patients were able to perform the protocol
and whether we were able to measure the typical fNIRS signal of neuronal activity.
Methods: We included 14 PD patients (age 71.2 ± 5.4 years, Hoehn and Yahr stage II/III). The protocol consisted of
five repetitions of three conditions: walking while (i) counting forwards, (ii) serially subtracting, and (iii) reciting digit
spans. Ability to complete this protocol, perceived exertion, burden of the fNIRS devices, and concentrations of
oxygenated (O2Hb) and deoxygenated (HHb) hemoglobin from the left and right PFC were measured.
Results: Two participants were unable to complete the protocol due to fatigue and mobility safety concerns. The
remaining 12 participants experienced no burden from the two fNIRS devices and completed the protocol with
ease. Bilateral PFC O2Hb concentrations increased during walking while serially subtracting (left PFC 0.46 μmol/L,
95 % confidence interval (CI) 0.12–0.81, right PFC 0.49 μmol/L, 95 % CI 0.14–0.84) and reciting digit spans (left PFC
0.36 μmol/L, 95 % CI 0.03–0.70, right PFC 0.44 μmol/L, 95 % CI 0.09–0.78) when compared to rest. HHb concentrations
did not differ between the walking tasks and rest.
Conclusions: These findings suggest that a new wireless fNIRS device is a feasible measure of PFC activity in PD during
dual task walking. Future studies should reduce the level of noise and inter-individual variability to enable measuring
differences in PFC activity between different dual walking conditions and across health states.
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Background
Many patients with Parkinson’s disease (PD) have diffi-
culties to perform a second task while walking (i.e., dual
task walking), such as walking and talking or walking
while paying attention to passing traffic [1]. As a conse-
quence of performing two tasks at the same time, gait
and/or their performance on the secondary task at hand
deteriorates [2–4]. These difficulties in dual task walking
often lead to increased disability, increased fall risk, and
reduced quality of life [1, 5, 6].
Mechanisms underlying difficulties in dual task walking
are largely unclear. However, the prefrontal cortex (PFC),
which is involved in human balance and locomotion [7],
likely plays an important role. Although cognitive func-
tions depending on the PFC are often affected in PD
[8–10], patients may rely more on the PFC due to re-
duced movement automaticity of dysfunctional basal
ganglia circuits [1, 11–13]. Therefore, altered function-
ing of the PFC during dual task walking in PD might
explain their difficulties and should therefore be further
examined.
Functional near-infrared spectroscopy (fNIRS) is a
promising method for measuring PFC activity during dual
task walking [14–16]. With fNIRS, relative concentrations of
oxygenated (O2Hb) and deoxygenated (HHb) hemoglobin
can be measured [17, 18]. In typical neural activity as mea-
sured with fNIRS, increases in O2Hb and stable or slight de-
creases in HHb are present [14, 16, 18, 19]. The use of
fNIRS offers several advantages over other neuroimaging
techniques. Compared to functional magnetic resonance im-
aging (fMRI), which has a higher spatial resolution and can
reach subcortical areas, fNIRS is lightweight, easy to use,
low cost, and can be portable [11, 14, 18]. Compared to
electroencephalography (EEG), which can also be used
during actual walking [20], fNIRS can provide higher
spatial resolution, is easier to use, and more robust to
head movement [14, 18, 21]. These advantages make
fNIRS particularly attractive to be used for measure-
ment during actual walking [11].
In healthy young and elderly persons, fNIRS was used
to detect increased PFC activity during walking while
talking [22, 23], while counting [24], and while serially
subtracting [24–26]. Compared to these populations, PD
patients generally are physically less fit. This might limit
their ability to perform multiple task repetitions, which
are needed for reliable fNIRS measurements. In addition,
PD patients often show altered movement patterns such
as restricted gait, dyskinesia, or bradykinesia. This might
influence head position and head movement during
walking and thereby further restrict the feasibility of
using fNIRS to measure PFC activity during dual task
walking.
Therefore, the primary aim of this pilot study was to
examine the feasibility of measuring bilateral PFC activity
in patients with PD during different dual task walking
conditions using two lightweight, wireless fNIRS devices
(Portalite fNIRS system). This was done in the context of
the V-TIME project [27, 28] in which we applied fNIRS to
study the role of the PFC in complex walking in PD pa-
tients. The first results of this project, which were re-
cently published [13], focus on potential mechanisms
underlying dual task difficulties in PD. Although outside
the scope of this recently published work, details of
pilot work concerning methodology and feasibility of using
fNIRS in PD are crucial for the development of new studies
to further disentangle the neural mechanisms underlying
dual tasking in PD.
As a start for the development of appropriate protocols
for such studies, this feasibility study incorporated several
specific goals. First, we assessed feasibility by testing
whether PD patients were able to perform several repe-
titions of dual task walking while wearing the devices and
by registering their experience and perceived exertion.
Second, we aimed to investigate whether we were able to
record the expected typical fNIRS signal of neuronal activ-
ity in the PFC (the neuronal hemodynamic response [18])
as a consequence of dual task walking when compared to
rest. We tested this at a group level, and at individual
level, to explore potential inter-individual variability. Fi-
nally, we explored the sensitivity of our method to detect
differences in O2Hb and HHb concentrations between
dual task walking and rest and between dual tasks.
Methods
Participants
We recruited PD patients (N = 14) from the outpatient
clinic of the Neurology Department of the Radboud Uni-
versity Medical Center in the Netherlands. This number
of 14 participants was based on similar studies in other
populations, in which 6 [29], 11 [22], and 17 [25] partici-
pants were sufficient to measure PFC activity during
walking tasks. Inclusion criteria were (1) age 60–85 years,
(2) clinical diagnosis of idiopathic Parkinson’s Disease,
according to the UK Brain Bank criteria, (3) Hoehn and
Yahr stage II to III (while on medication), (4) an increased
risk of falling as indicated by the treating physician, or
reflected by actual falling incidents within 6 months
prior to the study, and (5) able to walk at least 5 min
without help (walking aids were allowed). Exclusion cri-
teria were (1) psychiatric co-morbidities, (2) neurologic
co-morbidities in medical history, (3) co-morbidity of the
motor system which restricts gait, (4) clinical diagnosis of
dementia, (5) unable to comply with the test protocol, and
(6) severe freezing precluding safe participation.
Baseline characteristics
General demographic characteristics were assessed by
questionnaires. Education level was assessed based on
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the Dutch education system [30] using seven categories
(1 = less than primary school, 7 = university degree). The
Longitudinal Aging Study Amsterdam Physical Activity
Questionnaire (LAPAQ) [31] was completed to obtain
physical activity levels of the participants in 2 weeks be-
fore assessment, the Mini-Mental State Examination
(MMSE) to assess global cognitive functioning [32], and
the Fall Efficacy Scale International (FES-I) [33] to assess
fear of falling. Fall rate, disease duration, and medication
use were assessed by medical history taking of the sub-
jects and proxies, with a fall being defined as “an unex-
pected event in which the participant comes to rest on
the ground, floor or lower level,” which is consistent
with the recommendations of the Prevention of Falls
Network Europe (ProFaNE).
Protocol/procedure
Participants were instructed to walk back and forth over
a course of approximately 8 m which was marked by a
cone at each end and to make wide turns around the
cones. During all walking tasks, participants walked at
their preferred pace in a quiet room with comfortable
footwear. Participants were allowed to use a customary
cane, but walkers were not allowed during assessments.
Medication was used as normal, and thus, all tests were
performed in the on-medication state.
For dual task walking, three different types of tasks
were used: walking while (1) counting forward, (2) serially
subtracting, and (3) reciting digit spans. These tasks were
chosen because it can reasonably be assumed that PFC ac-
tivity is present during these tasks in PD [2–4, 34–39]. In
previous studies, dual task effects were seen on behavioral
outcome measures in PD during both walking while seri-
ally subtracting [2–4, 34–39] and while reciting digit spans
[40]. In addition to these behavioral findings, fNIRS was
successfully used in other populations to show increased
PFC activity during walking while counting forward [24]
and while serially subtracting [24–26].
During walking while counting forward, participants
were asked to count forward at their own pace, starting
from one. For serial subtraction, participants were instructed
to continuously count backward alternating in steps of three
or seven, starting from a number between 91 and 100.
When a participant started with serial seven subtractions,
we switched to serial three subtractions at the start of the
next trial, or when zero was reached. The digit span con-
sisted of repeating series of digits which the assessor said
out loud. The number of digits to be repeated was based on
the forward digit span of the Wechsler Adult Intelligence
Scale (WAIS-III) [41]. Before starting any task, participants
sat in a chair and repeated digit spans of increasing length.
If subjects were unable to correctly repeat two out of
three spans of the same length, the number of digits to
be repeated during walking while reciting digit spans
was one less than this length. If participants were unable
to correctly repeat a span of this length during walking
and stopped performing the digit span completely, the
span length was reduced until participants did engage
in the digit span during walking. This protocol was
used to adjust the difficulty of reciting digit spans to
each participant’s ability, thereby adjusting for baseline
differences [40].
Each of the walking tasks was performed five times
distributed over five blocks, with each block consisting
of three different trials (one of every task). The order of
these three trials within a block was randomized. Every
trial started with 20 s of standing still, followed by 40 s
of task performance, and another 20 s of standing still.
During the two 20-s rest periods, participants were
instructed to stand as quietly as possible, keep their
heads still, look straight ahead, and think of nothing in
particular. After 20 s of standing still, the assessor would
say “start” for walking while counting, “start with [first
number] minus [three or seven]” for walking while seri-
ally subtracting, and “start with [first digit span]” for
walking while reciting digit spans. After this start sign,
participants were instructed to start walking and simul-
taneously perform the cognitive task. After 40 s of task
performance, the assessor said “stop,” after which the
participant had to remain standing quietly where he or
she ended for 20 s.
In between trials, participants walked back toward
the start position and a rest period of random duration
(1–2 min) was given in which instructions for the next
trial were given. In between blocks, participants were
allowed to sit down and rest until they were ready to
continue. Before starting any trial, it was made sure the
participant was standing for at least 1 min to minimize
blood pressure fluctuations after standing up.
Feasibility assessment
To judge the feasibility of the protocol, participants were
asked to complete the Borg Rating of Perceived Exertion
Scale (RPE) [42], ranging from 6 (very light effort) to 20
(very very hard) after each block. After completion of
the protocol, participants were asked to complete a
questionnaire about their experience. This questionnaire
included: “Did the fNIRS system (Portalites) burden you
while walking?” (5 point Likert scale: 1 = “No, not at all”
and 5 = “Yes, a lot”) and “Was it doable to complete the
protocol?” (5 point Likert scale: 1 = “Yes, very easily do-
able” and 5 = “No, undoable”).
fNIRS system
In order to test whether we were able to measure the
typical fNIRS signal of neuronal activity, we measured
concentration changes in O2Hb and HHb in the PFC
with the PortaLite™ fNIRS system (Artinis Medical
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Systems, Elst, the Netherlands). Like other fNIRS systems,
this system uses near-infrared light which penetrates the
skull and brain, but absorbed by hemoglobin (Hb) chro-
mophores in the cortical layer microcirculation. Light
was transmitted with two wavelengths, 760 and 850 nm,
and data was sampled with a frequency of 10 Hz. The
PortaLite™ uses wireless technology (Bluetooth), allow-
ing participants to walk without restriction of wires.
Two devices were placed on the forehead of the partici-
pants, one on the right and the other on the left side.
Both devices were positioned at a height of 15 % of the
nasion-inion distance from nasion, and we placed the
middle of the device at 7 % of the head circumference
to the left and right from midline, to avoid measuring
the midline sinus. These locations roughly target left
and right Brodmann’s areas 9 and 10, which represent
the dorsolateral and anterior PFC [43, 44]. The devices
were shielded from ambient light by covering the whole
forehead with a black cloth. Oxysoft version 3.0.52
(Artinis Medical Systems, Elst, The Netherlands) was
used for data collection.
Based on different Hb absorption spectra, concentration
changes of O2Hb and HHb in the targeted PFC area were
calculated from the changes in detected light intensity.
This was done using the modified Lambert-Beer law, as-
suming constant light scattering [45]. A PortaLite™ has
three transmitters and one receiver, with transmitter-
receiver distances of 30, 35, and 40 mm. The differential
path length factor (DPF), which accounts for the increased
distance traveled by light due to scattering, was set to 6
for all participants. This is in line with previous studies in
adults [46]. Although the DPF is age-dependent [46], no
data is available on the actual DPF variation in adults
older than 50. With the fixed DPF we chose, the assess-
ment of relative changes in O2Hb and HHb within and
between tasks will not be affected.
fNIRS analysis
Measured concentrations of O2Hb and HHb from each
of the Portalite devices were exported to MATLAB
(MATLAB and Statistics Toolbox Release 2012b, The
MathWorks, Inc., Natick, Massachusetts, United States),
in which further data processing was done. First, O2Hb
and HHb signals of the three channels (the three
transmitter—receiver distances) per PortaLite were av-
eraged. Then, the moving standard deviation-based artifact
removal (movement artifact reduction algorithm—MARA)
method was performed within each trial [47]. The thresh-
old for artifact detection was set to 0.45 for O2Hb and 0.18
for HHb, with a window length for moving standard devi-
ation calculation at 0.5 s, and a window length for artifact
correction (LOESS smoothing window) on 1 s. These
parameters were chosen after testing several settings
and visual inspection of the data by JC and FN on
adequate removal of large (movement) artifacts while
not affecting physiological fluctuations. Next, the fNIRS
signals were linearly detrended per trial and low-pass
filtered at 0.1 Hz using a Butterworth filter to remove
heart rate and other higher frequency physiological sig-
nals. To enable direct comparison of the five different
trials within each task, the filtered signals were biased,
using the average concentration of the 5 s before the
“Start” instruction as reference (zero). Then, individual
trials were averaged per task to create three mean time
course signals per person, which were then averaged
over all participants (see Fig. 1). Finally, the mean con-
centrations (O2Hb and HHb) during the final 5 s of all
20-s rest periods were calculated over all trials for all
participants and mean concentrations (O2Hb and HHb)
of the 40 s after the “Start” instruction were calculated
for each trial and then averaged for each of the three
walking tasks.
Gait performance analysis
To be able to judge whether our protocol was able to
detect behavioral dual task effects and to interpret the
level of PFC activity in relation to behavioral perform-
ance, gait parameters, and performance on the cognitive
tasks were measured.
Walking performance parameters were measured on a
GAITRite® mat (CIR Systems Inc., Clifton, NJ 07012,
USA), over which the participants walked while walking
forth over the 8-m course. The GAITRite® mat is an
electronic roll-up walkway with pressure sensors embed-
ded in a carpet. The carpet is 5.18-m long and 0.90-m
wide, and the active area is 4.27-m long and 0.61-m
wide. The mat is connected to a personal computer
using GAITRite software version 4.0 (CIR Systems Inc.,
Clifton, NJ 07012, USA) for processing and storing the
data. This system has been shown to be reliable and ac-
curate for measuring walking parameters in elderly and
in people with PD [48–50]. For investigating gait under
dual task conditions in PD, it has been used as reference
[51]. Automatic identification of footsteps was checked
step by step for each trial and manually corrected where
necessary. Walking performance parameters included
gait speed, cadence, stride length, stride time, and the
coefficient of variability (CV) of both stride length and
stride time calculated as (standard deviation/mean)*100.
Gait performance outcome measures were determined
for individual trials first (with an average of 13.1 ± 2.9
footsteps) and then averaged over all trials within the
three tasks for further analysis.
Cognitive performance analysis
Cognitive performance measures included the number
of subtractions and digit spans completed within the
40 s of task performance and the percentage of correct
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answers on both tasks. Outcome measures on gait and
the cognitive tasks were determined for individual trials
first and then averaged over all trials within the three
tasks for further analysis.
Statistical analysis
Statistical analysis was performed using IBM SPSS Sta-
tistics Version 21. To estimate the level of activity and
noise, we calculated group means and 95 % confidence
intervals (CI) for both O2Hb and HHb concentrations.
Likewise, means and 95 % confidence intervals were cal-
culated for the behavioral performance measures.
To explore differences between tasks in O2Hb and
HHb concentrations and behavioral performance mea-
sures, we calculated Cohen’s dz effect sizes based on mean
difference scores [52]. Effect sizes of 0.2, 0.5, and 0.8 were
interpreted as small, medium, and large, respectively [53].
Differences between dual walking tasks were tested for
Fig. 1 fNIRS signal time courses for each task. Average time courses of oxygenated hemoglobin (O2Hb: dark, solid lines) and deoxygenated
hemoglobin (HHb: lighter, dotted lines) of all subjects (N = 12) for left and right prefrontal cortices, mean ± sem. Vertical black lines indicate start
and end of task performance. PFC prefrontal cortex
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significance with the Wilcoxon signed-rank test, with
P < .05 as threshold for statistical significance.
Results
Participants
After screening, 14 patients were found eligible and were
included in the study. One of these patients was unable
to safely perform the tests, and another patient came in
tired and stopped after two blocks because of fatigue.
These two participants (both male; 78 and 76 years old;
8 and 11 years since PD diagnosis; Hoehn and Yahr
stage 2 and 2.5; 6 and 0 falls in the previous 6 months)
were excluded from further analysis. Characteristics of
the remaining 12 participants are shown in Table 1. For
these participants, a total of 155 out of 180 intended
trials were included in analyses. Reasons for dropped
trials were inconsistent use of walking aid or inconsistent
length of digit spans to be recited. No trials were dropped
because of noisy fNIRS signals due to movement artifacts.
For all participants, at least three trials per task were in-
cluded in the analyses. Only one participant used a cane
during the trials that were included in analyses.
Feasibility analysis
Two of the initial 14 participants were unable to
complete the whole protocol (see above). The 12 partici-
pants included in the study reported that it was doable
to complete the full protocol (median Likert-scale score
1, range 1 (very easily doable) to 3 (neutral)). On aver-
age, the participants scored 10.6 ± 1.6 on the Borg-RPE,
corresponding to fairly light effort. Concerning the two
Portalite devices placed on their forehead, participants
reported that these did not burden them during walking
(median Likert-scale score 1, range 1 (no burden at all)
to 2 (no burden)).
Prefrontal cortical activity
PFC activity (group level)
Figure 1 shows the group averaged time course of O2Hb
and HHb concentrations in bilateral PFC during the
three dual walking tasks. In all tasks, the average O2Hb
concentrations increased from resting conditions after
starting the task and decreased again during rest after
task performance. HHb concentrations remained relatively
stable or showed slight reductions during task performance
when compared to rest. Thus, in all three dual walking
tasks, bilateral PFC activity patterns were found on a group
level.
Mean O2Hb and HHb concentrations in left and right
PFC during the three dual walking tasks are shown in
Table 2 (also see Additional file 1: Figure S1). During
walking while serially subtracting and walking while re-
citing digit spans, mean O2Hb concentrations in left and
right PFC were significantly higher than those during
rest (lower limit 95 % CI >0). Mean HHb concentrations
were similar between walking tasks and rest (95 % CI
includes 0). No significant differences between tasks
were seen in mean O2Hb or HHb concentrations in left
or right PFC. Effect sizes of the concentration differ-
ences between dual walking tasks were small (Table 3).
PFC activity (individual level)
The O2Hb and HHb signals were stable over the five trials
within participants (see Additional file 1: Figures S3-S7),
which indicates that the wireless fNIRS system reliably
measures PFC activity within subjects. However, we found
large variability between participants (see standard errors
in Fig. 1 and confidence intervals in Table 2). Therefore,
we explored differences in individual fNIRS signal patterns
and were able to identify five subgroups of participants
based on signal patterns. The authors FN and JC both
independently inspected the figures of each subject (in-
dividual trials and average), which resulted in two iden-
tical group distributions. Five participants had signals
as hypothesized (classic task related hemodynamic re-
sponse signal), an increase in O2Hb, and slight decrease
or stable HHb during task performance (see Additional
file 1: Figure S3). One participant showed an increased
O2Hb with stable HHb, but only at the start of task per-
formance (Additional file 1: Figure S4). Three partici-
pants were identified as non-responders, where both
O2Hb and HHb remained relatively stable during task
performance and for all task repetitions (Additional file 1:
Figure S5). Two participants showed an inverse response
during walking while counting; O2Hb decreased, while
HHb remained relatively stable or decreased slightly
(Additional file 1: Figure S6). During walking while serially
Table 1 Characteristics of participants (N = 12)
Age (years) 70.1 ± 5.4
Gender (men) 7
Years since diagnosis PD 5.7 ± 3.3
Hoehn and Yahr stage (2/2.5/3) 4/5/3
Walking aid in daily life (yes/no) 3/9
Number of falls in previous 6 months (0/1/2/7) 5/2/4/1
Education (possible range 1–7)a 5.7 ± 1.3
MMSE (possible range 0–30)b 27.4 ± 2.0
LAPAQ (kcals/day) 630.3 ± 712.1
FES-I (possible range 16–64)c 29.3 ± 8.2
Number of different medications used 5.3 ± 2.7
Values are mean ± standard deviation or frequency
PD Parkinson’s disease, MMSE Mini-Mental State Examination, LAPAQ Longitudinal
Aging Study Amsterdam Physical Activity Questionnaire, FES-I Fall Efficacy
Scale International
aAccording to Verhage and colleagues [30]
bHigher scores indicating better global cognitive functioning
cHigher scores indicating more fear of falling
Nieuwhof et al. Pilot and Feasibility Studies  (2016) 2:59 Page 6 of 11
subtracting and walking while reciting digit spans, these
two participants showed no inverse response but slight in-
creases in or stable O2Hb concentrations. Finally, one par-
ticipant showed a highly unexpected response, with an
initial increase in O2Hb and increase in HHb in the sec-
ond half of task performance (Additional file 1: Figure S7).
These subgroups could not be identified based on partici-
pant characteristics or task performance data, in which no
obvious differences between subgroups were present.
Behavioral performance
Gait performance during the dual walking tasks is shown
in Table 2 (also see Additional file 1: Figure S2). For gait
speed, cadence, stride time, and stride time variability,
no significant differences in gait performance between
any of the dual walking tasks were found. During walk-
ing while reciting digit spans, participants showed sig-
nificantly decreased stride length when compared to
walking while counting (z = −2.7, P = .006) and serially
subtracting (z = −2.1, P = .034) and increased stride length
variability when compared to walking while counting
(z = −2.6, P = .010). In addition to these significant dif-
ferences, for which effect sizes were medium to large
(Table 3), a medium effect size (Cohen’s dz = 0.72) was
found for gait speed during walking while counting ver-
sus reciting digit spans. All other effect sizes were small
(Table 3).
During walking while serially subtracting, participants
gave an average of 25.3 (95 % CI 19.7–30.8) answers, of
which on average, 98.4 % (95 % CI 97.5–99.3) was
Table 2 Concentrations of O2Hb and HHb and gait performance measures during all three walking tasks
Walking while counting Walking while serially subtracting Walking while reciting digit spans
fNIRS
O2Hb left (μmol/L) 0.32 (−0.18–0.82) 0.49 (0.14–0.84) 0.44 (0.09–0.78)
O2Hb right (μmol/L) 0.31 (−0.12–0.75) 0.46 (0.12–0.81) 0.36 (0.03–0.70)
HHb left (μmol/L) 0.03 (−0.28–0.33) 0.01 (−0.15–0.17) −0.03 (−0.16–0.10)
HHb right (μmol/L) 0.00 (−0.28–0.28) −0.02 (−0.25–0.21) −0.10 (−0.24–0.05)
Gait performance
Gait speed (cm/s) 83.7 (73.7–93.7) 82.3 (71.8–92.9) 79.9 (68.2–91.6)
Cadence (steps/min) 94.6 (86.2–103) 93.2 (84.6–101.9) 94.0 (84.0–104.0)
Stride length (cm) 106.3 (97.7–114.9) 106 (96.6–115.4) 101.2 (91.5–111.0)**
Stride length variability (%) 4.2 (3.2–5.2) 4.5 (2.9–6.2) 5.4 (4.4–6.5)*
Stride time (s) 1.3 (1.2–1.4) 1.3 (1.2–1.4) 1.3 (1.2–1.5)
Stride time variability (%) 4.2 (2.4–5.9) 4.0 (2.9–5.2) 3.6 (2.7–4.6)
Values are mean (95 % confidence intervals)
*P < .05 compared to walking while counting
**P < .05 compared to both walking while talking and serially subtracting
Table 3 Effect sizes (Cohen’s dz) between the walking tasks for both concentrations of O2Hb and HHb and gait performance
Walking while serially
subtracting > counting
Walking while reciting
digit spans > counting
Walking while serially subtracting >
reciting digit spans
fNIRS
O2Hb left .29 .08 .36
O2Hb right .31 .20 .27
HHb left −.13 −.36 .43
HHb right −.07 −.18 .42
Gait performance
Gait speed (m/s) −.22 −.72 .40
Cadence (steps/min) −.33 −.15 −.23
Stride length (m) −.09 −.93 .73
Stride length variability (%) .11 1.04 −.32
Stride time (s) .30 .16 .18
Stride time variability (%) −.05 −.20 .24
Effect sizes larger than 0.5 (medium effect) printed in bold
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correct. The mean length of digit spans to be repeated
during walking while reciting digit spans was 4.9 digits
(95 % CI 4.0–5.8). Two participants were unable to per-
form the predetermined length of digit spans during
walking; for them, the number of digits was reduced
until they were able to perform (from 6 to 5 and from 7
to 4 digits). During walking while reciting digit spans,
participants recited an average of 6.0 (95 % CI 5.2–6.8)
spans, with a mean success rate of 88.4 % (95 % CI
79.6–97.3).
Discussion
In this pilot study, we aimed to examine the feasibility of
measuring PFC activity during dual task walking in pa-
tients with PD with use of a portable fNIRS device.
Good feasibility of the portable fNIRS device was dem-
onstrated by the fact that most participants experienced
a low burden of the two fNIRS devices placed on the
forehead during walking, were able to perform the differ-
ent dual task walking paradigms, and reported that it
took them little effort to complete the full protocol. Im-
portantly, when averaged over all participants, fNIRS
showed typical cortical activity patterns of increased ox-
ygenated (O2Hb) and stable deoxygenated hemoglobin
(HHb) concentrations during the three dual walking
tasks when compared to rest. This further supports
feasibility of using portable fNIRS to measure PFC activ-
ity during dual task walking in PD.
These findings are in line with previous studies in
which fNIRS was successfully used to measure PFC ac-
tivity during dual task walking in healthy young adults
[24–26] and elderly [22, 23, 54]. In contrast to these
studies that found differences in PFC activity levels be-
tween walking tasks, effect sizes in our study were small.
Although we were able to measure PFC activity during
dual task walking, future protocols need to be improved
to enable detection of differences between tasks. This
can possibly be done by either reducing variability in
concentration measures (i.e., reducing noise), especially
between participants, or choosing different tasks. Below,
we will elaborate on these issues and propose protocol
improvements for future work.
Large variability occurred mainly between participants,
while time courses of O2Hb and HHb were highly stable
within participants. The first potential cause of such in-
ter-individual differences is the fNIRS optode placement
on the forehead. Although the placement procedure was
identical for all participants, it was based on relative dis-
tances from external landmarks (nasion and inion). It is
possible that this method resulted in the targeting of
slightly different brain areas due to morphological differ-
ences between subjects [19, 55]. To avoid targeting differ-
ent brain areas, it could be beneficial to relocate the
devices until task-related cortical activity is seen before
starting measurements. The window in which to move the
devices should however be limited, so that after relocation,
still the region of interest is likely targeted. Also, the typic-
ally expected response of the targeted brain area should
be very well known and distinct from directly surrounding
brain areas [19]. Another solution could be to use portable
multichannel fNIRS systems. When available, such a sys-
tem could cover the whole PFC, ensuring that the target
area is within the field of view [56, 57]. Another option is
to use structural magnetic resonance imaging or trans-
cranial magnetic stimulation before placing fNIRS
probes to enable more precise placement over a target
area, although these are costly and laborious solutions
[19]. A second cause of individual differences can be
systemic task responses (see also our discussion on the
study limitations) such as changes in blood pressure or
heart rate [58]. Adding continuous blood pressure and
heart rate monitoring can help to determine the role of
systemic responses in individual differences.
Future studies should try to limit individual differences
by optimizing protocols as suggested above. When still
present, causes of individual differences should be fur-
ther investigated and taken into account when determin-
ing sample sizes and when interpreting group averaged
data. Only in the case of obvious measurement errors
should a participant who shows non-hypothesized fNIRS
signals be excluded from analyses. For example, when it
can reasonably be assumed that the wrong cortical area
was targeted, when the data contains too much noise
due to movement artifacts, or when systemic changes in
blood pressure and subsequent changes in cerebral
perfusion affect the hemodynamic response to activity,
there are objective arguments to exclude a subject.
Apart from inter-individual differences, the choice of
walking tasks is an important topic for improvement of
future studies. First, although simple counting during
walking offers a controlled condition and prevents that
participants’ thoughts start to wander (“daydreaming”),
it might be a rather difficult dual task itself. Accordingly,
in healthy young participants walking while counting led
to increased PFC activity when compared to usual walk-
ing [24]. The dual tasks we used might thus not have
differed much in terms of difficulty, which would explain
the lack of differences in PFC activity levels between
tasks. This is further supported by the similar gait per-
formance we saw between walking while counting and
serially subtracting. And, although we did not measure it
as a single task, good performances on both serially sub-
tracting and reciting digit spans while walking suggest
that these tasks might not have been much more difficult
than walking while counting. Future studies should use
tasks that differ more in terms of difficulty, such as usual
walking without any secondary task. With usual walking
as a reference task, previous studies found relatively
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increased PFC activity during dual tasks like walking while
talking [22, 23], serially subtracting [24–26], and balancing
a ping pong ball on a card [29]. A second consideration
regarding the choice of task is the use of walking while
reciting digit spans. Effect sizes of the difference with
walking while counting for gait speed, stride length, and
stride length variability were moderate to large. However,
defining the number of digits to be recited was not
straightforward as reflected by the two participants who
were unable to perform the predefined length while walk-
ing. Also, citing the numbers seemed to provide partici-
pants with an external rhythm on which they paced their
walking. Finally, walking while serially subtracting showed
larger differences (effect sizes) with walking while count-
ing for O2Hb concentration change. Using walking while
reciting digit spans in future fNIRS dual task work is thus
not recommended.
A limitation of the present study was the small sample
size. Although the sample size was sufficient to fulfill our
primary aims regarding feasibility, it might have been too
low to find differences between dual walking tasks. Based
on the variability and mean difference in O2Hb concentra-
tion between walking while counting and walking while
serially subtracting in the present study, 85 participants
would be needed to find significant differences in O2Hb
concentrations between these tasks (power = 0.80, alpha =
0.05, two-tailed testing). However, improving protocols as
suggested, to reduce variability and increase contrasts be-
tween tasks, will reduce this required sample size. Indeed,
our recently published work shows that groups of 68 PD
patients and 38 healthy controls were sufficient to find
O2Hb concentration differences between complex walking
tasks within groups [13].
Also, we cannot generalize findings to the broader PD
population. Although all participants were identified with
an increased risk of falling, they were able to walk at least
5 min unassisted, their cognitive functioning was relatively
well, and all were in mild to moderate stages of PD.
Two patients who had passed screening for inclusion
and exclusion criteria were unable to complete the proto-
col. Although no large differences were present, these two
participants were slightly older and had a longer history of
PD than the mean of those participants who were able to
complete the protocol. This raises doubt whether the
protocol is feasible for more frail and severely affected PD
patients, which is a subject for future research.
Other limitations concern our use of fNIRS. We did
not control for superficial (e.g., skin) hemodynamics
[59, 60], for example, by using a short reference channel
[59]. Thus, we cannot rule out the influence of blood flow
through skin or the occipitofrontalis muscle, which might
have increased during task performance [61]. However, in
frontal brain areas, high correlations were found between
fNIRS signals and fMRI signals from the cortical gray
matter layer while performing several cognitive tasks
[62, 63]. These correlations were higher than correlations
between fNIRS signals and soft tissue fMRI signals [62].
Although our fNIRS signals are likely affected by skin
blood flow, we can still assume based on these data that
they do reflect cortical neuronal activity. A further limita-
tion is that only PFC activity levels were measured. We
did not measure any other cortical areas to ensure specifi-
city of signals to PFC instead of whole brain effects. The
use of a multiple channel fNIRS system would allow for
measurements of multiple cortical areas and thereby to
differentiate between region-specific and global effects;
however, the increase in weight of such a system may
reduce the feasibility. Besides cognitive tasks, postural
changes and walking exercise may all lead to changes in
blood pressure which in turn can affect global cerebral
blood flow [18]. For this reason, it is advisable to meas-
ure blood pressure simultaneously with fNIRS.
Conclusions
In this study, we showed that using two small, light-
weight, portable fNIRS devices placed on the forehead is
feasible to measure PFC activity during dual task walking
in PD patients. We provided recommendations for im-
provements of protocols to increase the sensitivity to de-
tect differences in PFC activity and behavioral performance
between dual walking tasks and potentially between
populations (PD patients vs. healthy age-matched controls)
and/or changes over time (neurorehabilitation training ef-
fects). With improved protocols, portable fNIRS seems to
be a very promising tool to further study the role of the
PFC in mechanisms underlying difficulties in dual task
walking in PD.
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